Julie Naud

486 total citations
14 papers, 386 citations indexed

About

Julie Naud is a scholar working on Epidemiology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Julie Naud has authored 14 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 6 papers in Infectious Diseases and 5 papers in Organic Chemistry. Recurrent topics in Julie Naud's work include HIV/AIDS drug development and treatment (6 papers), Hepatitis C virus research (5 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). Julie Naud is often cited by papers focused on HIV/AIDS drug development and treatment (6 papers), Hepatitis C virus research (5 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). Julie Naud collaborates with scholars based in Canada, Egypt and Germany. Julie Naud's co-authors include Christiane Yoakim, Bruno Haché, William W. Ogilvie, Robert Déziel, Jeff A. O’Meara, Nathalie Goudreau, Michael G. Cordingley, Dale R. Cameron, Peter W. White and Ingrid Guse and has published in prestigious journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Julie Naud

13 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julie Naud Canada 12 200 116 78 75 72 14 386
Savina Malancona Italy 13 215 1.1× 122 1.1× 75 1.0× 101 1.3× 107 1.5× 21 413
Jeff A. O’Meara Canada 14 261 1.3× 225 1.9× 95 1.2× 94 1.3× 39 0.5× 21 587
Frantz Victor United States 11 237 1.2× 127 1.1× 59 0.8× 96 1.3× 83 1.2× 15 400
John A. Bender United States 12 286 1.4× 97 0.8× 55 0.7× 118 1.6× 80 1.1× 18 459
Bruno Haché Canada 9 365 1.8× 100 0.9× 64 0.8× 51 0.7× 41 0.6× 12 500
Naoki Ogura Japan 9 187 0.9× 91 0.8× 117 1.5× 45 0.6× 117 1.6× 19 374
Shintaro Hirashima Japan 8 255 1.3× 76 0.7× 71 0.9× 99 1.3× 142 2.0× 8 428
John Pichardo United States 15 153 0.8× 163 1.4× 120 1.5× 146 1.9× 205 2.8× 30 458
Emanuela Nizi Italy 13 302 1.5× 238 2.1× 96 1.2× 159 2.1× 49 0.7× 19 609
David D. Deininger United States 9 88 0.4× 216 1.9× 107 1.4× 186 2.5× 44 0.6× 14 417

Countries citing papers authored by Julie Naud

Since Specialization
Citations

This map shows the geographic impact of Julie Naud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Naud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Naud more than expected).

Fields of papers citing papers by Julie Naud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Naud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Naud. The network helps show where Julie Naud may publish in the future.

Co-authorship network of co-authors of Julie Naud

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Naud. A scholar is included among the top collaborators of Julie Naud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Naud. Julie Naud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Bilodeau, François, Murray D. Bailey, Josée Bordeleau, et al.. (2013). Synthesis and optimization of a novel series of HCV NS3 protease inhibitors: 4-Arylproline analogs. Bioorganic & Medicinal Chemistry Letters. 23(14). 4267–4271. 4 indexed citations
2.
Beaulieu, Pierre L., René Coulombe, Jianmin Duan, et al.. (2013). Structure-based design of novel HCV NS5B thumb pocket 2 allosteric inhibitors with submicromolar gt1 replicon potency: Discovery of a quinazolinone chemotype. Bioorganic & Medicinal Chemistry Letters. 23(14). 4132–4140. 21 indexed citations
3.
Llinàs‐Brunet, Montse, Murray D. Bailey, Nathalie Goudreau, et al.. (2010). Discovery of a Potent and Selective Noncovalent Linear Inhibitor of the Hepatitis C Virus NS3 Protease (BI 201335). Journal of Medicinal Chemistry. 53(17). 6466–6476. 57 indexed citations
4.
Naud, Julie, Alain Olivier, André Bélanger, & Line Lapointe. (2009). Medicinal understory herbaceous species cultivated under different light and soil conditions in maple forests in southern Québec, Canada. Agroforestry Systems. 79(3). 303–326. 16 indexed citations
5.
Kawai, Stephen H., Murray D. Bailey, Ted Halmos, et al.. (2008). The Use of Chemical Double‐Mutant Cycles in Biomolecular Recognition Studies: Application to HCV NS3 Protease Inhibitors. ChemMedChem. 3(11). 1654–1657. 13 indexed citations
6.
Naud, Julie, et al.. (2008). Potent triazolyl-proline-based inhibitors of HCV NS3 protease. Bioorganic & Medicinal Chemistry Letters. 18(11). 3400–3404. 24 indexed citations
7.
8.
O’Meara, Jeff A., Christiane Yoakim, Pierre Bonneau, et al.. (2005). Novel 8-Substituted Dipyridodiazepinone Inhibitors with a Broad-Spectrum of Activity against HIV-1 Strains Resistant to Non-nucleoside Reverse Transcriptase Inhibitors. Journal of Medicinal Chemistry. 48(17). 5580–5588. 15 indexed citations
9.
Yoakim, Christiane, William W. Ogilvie, Nathalie Goudreau, et al.. (2003). Discovery of the First Series of Inhibitors of Human Papillomavirus Type 11: Inhibition of the Assembly of the E1—E2—Origin DNA Complex. ChemInform. 34(44). 1 indexed citations
10.
Yoakim, Christiane, Pierre Bonneau, Robert Déziel, et al.. (2003). Novel nevirapine-like inhibitors with improved activity against NNRTI-resistant HIV: 8-heteroarylthiomethyldipyridodiazepinone derivatives. Bioorganic & Medicinal Chemistry Letters. 14(3). 739–742. 22 indexed citations
11.
Yoakim, Christiane, William W. Ogilvie, Nathalie Goudreau, et al.. (2003). Discovery of the first series of inhibitors of human papillomavirus type 11: inhibition of the assembly of the E1–E2–Origin DNA complex. Bioorganic & Medicinal Chemistry Letters. 13(15). 2539–2541. 53 indexed citations
12.
Ogilvie, William W., Christiane Yoakim, Florence Dô, et al.. (1999). Synthesis and antiviral activity of monobactams inhibiting the human cytomegalovirus protease. Bioorganic & Medicinal Chemistry. 7(8). 1521–1531. 41 indexed citations
13.
Yoakim, Christiane, Dale R. Cameron, Catherine Chabot, et al.. (1998). Potent β-Lactam Inhibitors of Human Cytomegalovirus Protease. Antiviral chemistry & chemotherapy. 9(5). 379–387. 27 indexed citations
14.
Yoakim, Christiane, William W. Ogilvie, Dale R. Cameron, et al.. (1998). β-Lactam Derivatives as Inhibitors of Human Cytomegalovirus Protease. Journal of Medicinal Chemistry. 41(15). 2882–2891. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Savina Malancona Breakdown of academic impact, for papers by Jeff A. O’Meara Breakdown of academic impact, for papers by Frantz Victor Breakdown of academic impact, for papers by John A. Bender Breakdown of academic impact, for papers by Bruno Haché Breakdown of academic impact, for papers by Naoki Ogura Breakdown of academic impact, for papers by Shintaro Hirashima Breakdown of academic impact, for papers by John Pichardo Breakdown of academic impact, for papers by Emanuela Nizi Breakdown of academic impact, for papers by David D. Deininger
Rankless by CCL
2026